Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
PALTAC, 2% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 15 yen
8283 PALTAC CORPORATION 【J-GAAP】
Earnings ReportPALTAC CORPORATION <8283> [TSE Prime] announced its financial results after the market closed on May 12th (15:30). The ordinary profit (non-consolidated) for the fiscal year ending March 2025 increased 3.7% from the previous period to 31.6 billion yen. For the fiscal year ending March 2026, the ordinary profit is expected to grow by 1.6% to 32.2 billion yen, marking the third consecutive term of record-high profits. This will be the fifth consecutive term of revenue and the third consecutive term of profit growth.
At the same time, the company has decided to increase the dividend this fiscal year to 120 yen, an increase of 15 yen from the previous fiscal year.
In the most recent three-month period, from January to March (4Q), the ordinary profit grew 6.5% from the same period last year, reaching 6.26 billion yen. The operating profit margin remained almost flat, changing from 1.9% in the same period last year to 2.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 1,104,152 | 24,472 | 27,440 | 19,251 | 306.3 | 82 | May 11, 2023 | J-GAAP |
| Mar, 2024 | 1,151,966 | 27,172 | 30,545 | 20,638 | 328.4 | 94 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 1,188,097 | 28,008 | 31,684 | 22,864 | 366.5 | 105 | May 12, 2025 | J-GAAP |
| YoY | +3.1% | +3.1% | +3.7% | +10.8% | +11.6% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 1,190,000 | 28,000 | 31,700 | 22,000 | 356.7 | 105 | May 13, 2024 | J-GAAP |
| Mar, 2025 Results | 1,188,097 | 28,008 | 31,684 | 22,864 | 366.5 | 105 | May 12, 2025 | J-GAAP |
| Revision Rate | -0.2% | +0.0% | -0.1% | +3.9% | +2.7% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 600,427 | 13,977 | 16,180 | 11,896 | 189.5 | 50 | Oct 28, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 622,000 | 14,600 | 16,200 | 11,100 | 180.3 | 57 | May 12, 2025 | J-GAAP |
| YoY | +3.6% | +4.5% | +0.1% | -6.7% | -4.8% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 1,151,966 | 27,172 | 30,545 | 20,638 | 328.4 | 94 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 1,188,097 | 28,008 | 31,684 | 22,864 | 366.5 | 105 | May 12, 2025 | J-GAAP |
| Mar, 2026 Guidance | 1,230,000 | 29,000 | 32,200 | 22,000 | 359.6 | 120 | May 12, 2025 | J-GAAP |
| YoY | +3.5% | +3.5% | +1.6% | -3.8% | -1.9% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 268,924 | 5,204 | 5,886 | 3,494 | 55.6 | 1.9 | May 13, 2024 | J-GAAP |
| Apr - Jun, 2024 | 302,914 | 7,428 | 8,305 | 6,076 | 96.7 | 2.5 | Jul 29, 2024 | J-GAAP |
| Jul - Sep, 2024 | 297,513 | 6,549 | 7,875 | 5,820 | 92.7 | 2.2 | Oct 28, 2024 | J-GAAP |
| Oct - Dec, 2024 | 310,637 | 8,462 | 9,237 | 6,386 | 102.0 | 2.7 | Feb 3, 2025 | J-GAAP |
| Jan - Mar, 2025 | 277,033 | 5,569 | 6,267 | 4,582 | 73.4 | 2.0 | May 12, 2025 | J-GAAP |
| YoY | +3.0% | +7.0% | +6.5% | +31.1% | +32.1% |
Related Articles
TACHIBANA ELETECH, 8% Decrease in Ordinary Profit for The Current Fiscal Year
SAPPORO CLINICAL LAB, 9% Increase in Ordinary Profit for The Current Fiscal Year
MT GENEX, 39% Increase in Ordinary Profit, Record High for The First Time in Fifteen Years
UNIVANCE, 54% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 1 yen, This Fiscal Year to Increase Dividend by 2 yen
Medical Data Vision, Jan-Mar (1Q) Ordinary Profit Decreases by 9%
Showa Sangyo, 4% Decrease in Ordinary Profit for The Current Fiscal Year
NAGANO KEIKI , 9% Decrease in Ordinary Profit for The Current Fiscal Year
Yamadai, Last Fiscal Year Net Income Loss Widened in Downward Revision, 40% Deficit Against Net Assets, Dividend Revised down by 10 yen
KIMURA, 19% Decrease in Ordinary Profit for The Current Fiscal Year
Taisei Lamick, 27% Decrease in Ordinary Profit for The Current Fiscal Year